Phathom Pharmaceuticals, Inc. PHAT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $875.45M.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s market capitalization?
- Phathom Pharmaceuticals, Inc. (PHAT) reported market capitalization of $875.45M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s market capitalization changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s market capitalization increased by 100.5% year-over-year, from $436.62M to $875.45M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s market capitalization has grown at a 2.3% compound annual growth rate (CAGR), from $1.05B to $1.18B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.